Pharmacotherapy

Papers
(The H4-Index of Pharmacotherapy is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Remdesivir: Review of Pharmacology, Pre‐clinical Data, and Emerging Clinical Experience for COVID‐19188
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019151
Baricitinib: A Review of Pharmacology, Safety, and Emerging Clinical Experience in COVID‐19138
COVID‐19 Clinical Diagnostics and Testing Technology101
Therapeutic Potential for Tetracyclines in the Treatment of COVID‐1987
Considerations for Statin Therapy in Patients with COVID‐1978
Managing COVID‐19 in Renal Transplant Recipients: A Review of Recent Literature and Case Supporting Corticosteroid‐sparing Immunosuppression67
Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management62
A guide to therapeutic drug monitoring of β‐lactam antibiotics61
Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID‐1954
Delayed Initiation of Remdesivir in a COVID‐19‐Positive Patient48
Vancomycin‐Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention46
Acetylcysteine for the Treatment of Suspected Remdesivir‐Associated Acute Liver Failure in COVID‐19: A Case Series43
Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the I36
Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective33
Advantages of Outpatient Treatment with Long‐Acting Lipoglycopeptides for Serious Gram‐Positive Infections: A Review28
Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug‐Resistant Gram‐Negative Pathogens28
Meta‐analysis of clinical outcomes of PCSK9 modulators in patients with established ASCVD26
Drug‐Induced Ototoxicity: A Comprehensive Review and Reference Guide26
Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis25
An Overview of the Treatment of Less Common Non–Lactose‐Fermenting Gram‐Negative Bacteria25
Approach to the Treatment of Patients with Serious Multidrug‐Resistant Pseudomonas aeruginosa Infections25
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review24
Treatment of patients with serious infections due to carbapenem‐resistant Acinetobacter baumannii: How viable are the current options?23
Optimizing anticoagulation for patients receiving Impella support23
0.027040958404541